Trial NCT02201381

View at ClinicalTrials.gov 
Org. Study IDs: Metabolic Cancer 001

Last trial update was posted on 2022-07-18

MeSH Interventions

Atorvastatin Doxycycline Mebendazole Metformin

MeSH Conditions


Other Conditions

Cancer Overall Survival

Stopping Reasons

Prospective recruitment not possible

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID